S&P 500
(0.03%) 5 088.80 points
Dow J
(0.16%) 39 132 points
Nasdaq
(-0.28%) 15 997 points
Oil
(-0.46%) $76.14
Gas
(10.29%) $1.768
Gold
(-0.27%) $2 043.80
Silver
(0.37%) $23.07
Platinum
(-0.78%) $902.55
USD/EUR
(0.06%) $0.925
USD/NOK
(0.17%) $10.55
USD/GBP
(0.08%) $0.790
USD/RUB
(0.11%) $93.70

Realtime updates for Burning Rock Biotech Ltd [BNR]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research
Last Updated23 Feb 2024 @ 15:59

1.36% $ 0.810

Live Chart Being Loaded With Signals

Commentary (23 Feb 2024 @ 15:59):
Profile picture for Burning Rock Biotech Ltd

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services...

Stats
Today's Volume 28 340.00
Average Volume 77 493.00
Market Cap 90.92M
EPS $-0.230 ( 2023-11-30 )
Next earnings date ( $0 ) 2024-03-26
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.840
ATR14 $0.0130 (1.60%)

Volume Correlation

Long: 0.17 (neutral)
Short: -0.79 (moderate negative)
Signal:(44.983) Neutral

Burning Rock Biotech Ltd Correlation

10 Most Positive Correlations
BLTE0.92
SOPA0.918
PHCF0.917
ONCR0.911
IART0.903
MLAB0.901
HIBB0.893
VLCN0.889
JRJC0.887
CBLI0.885
10 Most Negative Correlations
AVGO-0.935
SMCI-0.934
NVDA-0.933
BWC-0.922
HGBL-0.917
BSY-0.914
ELTK-0.914
ACLS-0.911
BOTZ-0.911
AIB-0.911

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Burning Rock Biotech Ltd Correlation - Currency/Commodity

The country flag -0.54
( weak negative )
The country flag -0.44
( neutral )
The country flag 0.00
( neutral )
The country flag -0.47
( neutral )
The country flag 0.00
( neutral )
The country flag 0.27
( neutral )

Burning Rock Biotech Ltd Financials

Annual 2022
Revenue: $563.24M
Gross Profit: $380.04M (67.47 %)
EPS: $-9.35
Q3 2023
Revenue: $127.57M
Gross Profit: $85.92M (67.35 %)
EPS: $-1.710
Q2 2023
Revenue: $146.27M
Gross Profit: $100.42M (68.66 %)
EPS: $-1.280
Q1 2023
Revenue: $142.52M
Gross Profit: $98.77M (69.31 %)
EPS: $-1.810

Burning Rock Biotech Ltd

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and OncoScreen ParpMatch and OncoCompass ParpMatch to target critical genes associated with homologous recombination deficiency. In addition, the company has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China. It has collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. The company was incorporated in 2014 and is headquartered in Guangzhou, China.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators